Madeleine L. Burg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Madeleine L. Burg has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Siamak Daneshmand
USC/Norris Comprehensive Cancer Center
5 shared publications Anne K. Schuckman
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
3 shared publicationsHooman Djaladat
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
3 shared publications- Hooman Djaladat
Institute of Urology, Norris Comprehensive Cancer Center University of Southern California Los Angeles CA USA
3 shared publications Ankeet Shah
Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, United States
2 shared publicationsDaniel E. Zainfeld
Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, United States
2 shared publications
Latest Publications
- 9 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (2) , 367-371
Trends in the Treatment of Stress Urinary Incontinence in a Tertiary Care Center After the Introduction of Polyacrylamide Hydrogel
Introduction: For women with bothersome stress urinary incontinence (SUI), a urethral sling is the gold‐standard surgical treatment. Despite the high efficacy of slings for SUI, up to a 20%–30% rate of complications or adverse effects have been reported, and there can be a period of convalescence postoperatively. Given this, the less invasive approach of urethral bulking may be utilized. A number of bulking agents can be used to improve urethra coaptation. Polyacrylamide hydrogel (PAHG) is a bulking agent that received FDA approval in 2020 and is reported to have longer efficacy for the treatment of SUI compared to prior bulking agents. We sought to assess trends in the usage of surgery and urethral bulking for SUI treatment in women at a single academic medical center before and after the introduction of PAHG. Methods: This is a retrospective cohort study of all new patients seen with an ICD‐10 diagnosis of SUI (N39.3) at an academic tertiary care center from June 2019 to June 2023. Our multidisciplinary clinic was established in May 2019. Patients were included if they underwent an interventional treatment for SUI with urethral bulking, sling (either mesh or autologous fascia), or Burch colposuspension. Patients were stratified to before and after the introduction of PAHG to our clinic in April 2021. The primary endpoint was the percent of new patients seen in clinic with SUI who were treated with urethral bulking compared to surgical treatment. Results: A total of 478 new patients with SUI were seen and 279 treated with an invasive procedure by 5 URPS trained surgeons. In total, 109 of these patients underwent treatment in the 20 months before PAHG was introduced into the clinic and 170 patients in the 27 months after. Use of urethral bulking for new patients seen for SUI increased from 56% to 69.1% ( p = 0.04) of patients with SUI who underwent a procedure. When the total number of new patients presenting with a diagnosis of SUI was analyzed by 12‐month period, there was an overall increase in the number of procedures for SUI, which was driven by an increase in the percent of new patients who were treated with bulking. Conclusions: The introduction of a PAHG resulted in increased utilization of urethral bulking for patients newly presenting with SUI to a tertiary care center.
- 9 December 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (2) , 367-371
Trends in the Treatment of Stress Urinary Incontinence in a Tertiary Care Center After the Introduction of Polyacrylamide Hydrogel
Introduction: For women with bothersome stress urinary incontinence (SUI), a urethral sling is the gold‐standard surgical treatment. Despite the high efficacy of slings for SUI, up to a 20%–30% rate of complications or adverse effects have been reported, and there can be a period of convalescence postoperatively. Given this, the less invasive approach of urethral bulking may be utilized. A number of bulking agents can be used to improve urethra coaptation. Polyacrylamide hydrogel (PAHG) is a bulking agent that received FDA approval in 2020 and is reported to have longer efficacy for the treatment of SUI compared to prior bulking agents. We sought to assess trends in the usage of surgery and urethral bulking for SUI treatment in women at a single academic medical center before and after the introduction of PAHG. Methods: This is a retrospective cohort study of all new patients seen with an ICD‐10 diagnosis of SUI (N39.3) at an academic tertiary care center from June 2019 to June 2023. Our multidisciplinary clinic was established in May 2019. Patients were included if they underwent an interventional treatment for SUI with urethral bulking, sling (either mesh or autologous fascia), or Burch colposuspension. Patients were stratified to before and after the introduction of PAHG to our clinic in April 2021. The primary endpoint was the percent of new patients seen in clinic with SUI who were treated with urethral bulking compared to surgical treatment. Results: A total of 478 new patients with SUI were seen and 279 treated with an invasive procedure by 5 URPS trained surgeons. In total, 109 of these patients underwent treatment in the 20 months before PAHG was introduced into the clinic and 170 patients in the 27 months after. Use of urethral bulking for new patients seen for SUI increased from 56% to 69.1% ( p = 0.04) of patients with SUI who underwent a procedure. When the total number of new patients presenting with a diagnosis of SUI was analyzed by 12‐month period, there was an overall increase in the number of procedures for SUI, which was driven by an increase in the percent of new patients who were treated with bulking. Conclusions: The introduction of a PAHG resulted in increased utilization of urethral bulking for patients newly presenting with SUI to a tertiary care center.
- Open Access
- 13 September 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 213 (1) , 60-70
Eleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors
Purpose:A midline extraperitoneal approach for retroperitoneal lymph node dissection (EP-RPLND) has been associated with decreased morbidity compared to the transperitoneal approach. We aimed to re...
- 13 September 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 213 (1) , 60-70
Open AccessEleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors
Purpose:A midline extraperitoneal approach for retroperitoneal lymph node dissection (EP-RPLND) has been associated with decreased morbidity compared to the transperitoneal approach. We aimed to re...
- 20 December 2023
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 21 (2) , 117-121
Gender disparities among publications within international sexual medicine urology journals and the impact of blinding in the review process
While female urologists are known to publish at less frequency than their male peers, The Journal of Sexual Medicine was reported to have among the highest growth in female authorship from 2002 to 2020 in urology journals. We sought to assess the frequency of female authorship in sexual medicine journals worldwide and the factors that affect this, including the blinded/unblinded review process. Eleven sexual medicine journals were assessed for geographic location, peer review method, and SCImago Journal Rank citation index (a metric of citation frequency and prestige). Journals were grouped into top, middle, and bottom quartiles based on metric score. Web of Science was used to access the publications’ first, second, last, and corresponding authors from the past 5 years. An internet search or Gender-API.com was used to determine the gender identities of authors. Univariate and multivariable logistic regression models were performed. Outcomes included the likelihood of female authorship (first, second, last, and corresponding) based on journal location and ranking, the clustering of female authors, the journal’s peer review process, and the frequency of female editorial board members. Overall, 8938 publications were identified. Women represented 30.7%, 31.3%, 21.3%, and 18.7% of the first, second, last, and corresponding authors, respectively; gender was unable to be assessed for 2.6%, 17.2%, 7.3%, and 2.7%. On univariate analysis, journals from North America, in the top quartile, and with a double-blind review process were more likely to have female authors (P < .001). On multivariate analysis, articles were more likely to have a female first author if they had a double-blind peer review process (odds ratio [OR], 1.20; 95% CI, 1.02-1.40), a female second author (OR, 2.54; 95% CI, 2.26-2.85), or a female corresponding author (OR, 7.80; 95% CI, 6.69-9.10). Gender-concordant mentoring and universal double-blind manuscript review processes may minimize the impact of gender bias and increase female authorship rates, in turn producing more diverse research. This is the first study assessing female authorship in sexual medicine journals. Limitations include not assessing every author listed on articles and being unable to determine gender identities for some authors. Female authorship rates are higher than reported rates of practicing female urologists but still lower than their male peers. Female authors were more likely to be published in journals with double-blind peer review processes and when publishing with additional female authors.
- 20 December 2023
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 21 (2) , 117-121
Gender disparities among publications within international sexual medicine urology journals and the impact of blinding in the review process
While female urologists are known to publish at less frequency than their male peers, The Journal of Sexual Medicine was reported to have among the highest growth in female authorship from 2002 to 2020 in urology journals. We sought to assess the frequency of female authorship in sexual medicine journals worldwide and the factors that affect this, including the blinded/unblinded review process. Eleven sexual medicine journals were assessed for geographic location, peer review method, and SCImago Journal Rank citation index (a metric of citation frequency and prestige). Journals were grouped into top, middle, and bottom quartiles based on metric score. Web of Science was used to access the publications’ first, second, last, and corresponding authors from the past 5 years. An internet search or Gender-API.com was used to determine the gender identities of authors. Univariate and multivariable logistic regression models were performed. Outcomes included the likelihood of female authorship (first, second, last, and corresponding) based on journal location and ranking, the clustering of female authors, the journal’s peer review process, and the frequency of female editorial board members. Overall, 8938 publications were identified. Women represented 30.7%, 31.3%, 21.3%, and 18.7% of the first, second, last, and corresponding authors, respectively; gender was unable to be assessed for 2.6%, 17.2%, 7.3%, and 2.7%. On univariate analysis, journals from North America, in the top quartile, and with a double-blind review process were more likely to have female authors (P < .001). On multivariate analysis, articles were more likely to have a female first author if they had a double-blind peer review process (odds ratio [OR], 1.20; 95% CI, 1.02-1.40), a female second author (OR, 2.54; 95% CI, 2.26-2.85), or a female corresponding author (OR, 7.80; 95% CI, 6.69-9.10). Gender-concordant mentoring and universal double-blind manuscript review processes may minimize the impact of gender bias and increase female authorship rates, in turn producing more diverse research. This is the first study assessing female authorship in sexual medicine journals. Limitations include not assessing every author listed on articles and being unable to determine gender identities for some authors. Female authorship rates are higher than reported rates of practicing female urologists but still lower than their male peers. Female authors were more likely to be published in journals with double-blind peer review processes and when publishing with additional female authors.
- Open Access
- 1 January 2021
- Published by Elsevier in Urology Case Reports
- Vol. 34, 101430
Full thickness penile skin necrosis following HIPEC: Case report and literature review
- 1 January 2021
- Published by Elsevier in Urology Case Reports
- Vol. 34, 101430
Open AccessFull thickness penile skin necrosis following HIPEC: Case report and literature review
- 1 September 2020
- Published by SAGE Publications in Journal of Endourology
- Vol. 34 (9) , 974-980
Natural History of Radiologic Incisional Hernia Following Robotic Nephrectomy
Objective To evaluate the incidence and natural history of radiologic incisional hernia (IH) in patients who underwent robotic partial or radical nephrectomy. Materials and Methods We retrospectively reviewed the records of patients who underwent robotic partial or radical nephrectomy for kidney tumor in our institution between January 2011 and April 2017. All pre and postoperative imagings were re-reviewed for detection of IH per Tonouchi classification. Patients who developed hernia were followed up and classified into stable or progressive group. Clinical findings and radiologic features of these patients are reported. Results A total of 247 patients (169 partial and 78 radical nephrectomy) were included in the study. The incidence of radiologic IH was 27.53%, graded as early-onset (35.3%), late-onset (51.5%) and bowel/fat-containing (13.2%). Median time to radiologic IH was 1.7 years. During the follow up of 68 patients who developed hernia, 33 (48.5%) had progressive and 8 (11.7%) developed clinical hernia. Median time to progression was 1.5 years. On multivariable analysis, adjuvant therapy was an independent predictor for radiologic hernia development (HR 3.23). Pathologic T stage ≥ 2 and history of open abdominal surgery were also significantly associated with hernia progression (HR 3.93 and 3.47, respectively). Conclusions Radiologic incisional hernia following robotic partial or radical nephrectomy is common. Progression rate is as high as 50% with median time to progression of 1.5 years. Adjuvant therapy is an independent predictor for IH development, while higher stage and history of open abdominal surgery are associated with IH progression.
- 1 September 2020
- Published by SAGE Publications in Journal of Endourology
- Vol. 34 (9) , 974-980
Natural History of Radiologic Incisional Hernia Following Robotic Nephrectomy
Objective To evaluate the incidence and natural history of radiologic incisional hernia (IH) in patients who underwent robotic partial or radical nephrectomy. Materials and Methods We retrospectively reviewed the records of patients who underwent robotic partial or radical nephrectomy for kidney tumor in our institution between January 2011 and April 2017. All pre and postoperative imagings were re-reviewed for detection of IH per Tonouchi classification. Patients who developed hernia were followed up and classified into stable or progressive group. Clinical findings and radiologic features of these patients are reported. Results A total of 247 patients (169 partial and 78 radical nephrectomy) were included in the study. The incidence of radiologic IH was 27.53%, graded as early-onset (35.3%), late-onset (51.5%) and bowel/fat-containing (13.2%). Median time to radiologic IH was 1.7 years. During the follow up of 68 patients who developed hernia, 33 (48.5%) had progressive and 8 (11.7%) developed clinical hernia. Median time to progression was 1.5 years. On multivariable analysis, adjuvant therapy was an independent predictor for radiologic hernia development (HR 3.23). Pathologic T stage ≥ 2 and history of open abdominal surgery were also significantly associated with hernia progression (HR 3.93 and 3.47, respectively). Conclusions Radiologic incisional hernia following robotic partial or radical nephrectomy is common. Progression rate is as high as 50% with median time to progression of 1.5 years. Adjuvant therapy is an independent predictor for IH development, while higher stage and history of open abdominal surgery are associated with IH progression.
- 1 July 2020
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (7) , 642.e1-642.e9
Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studies
- 1 July 2020
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (7) , 642.e1-642.e9
Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studies
- 1 January 2019
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (1) , 40-47
Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments
- 1 January 2019
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (1) , 40-47
Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 199 (4) , e336
MP26-04 WEARABLE FITNESS TRACKERS FOR MEASUREMENT OF BEHAVIORAL PATTERNS AMONG PATIENTS UNDERGOING RADICAL CYSTECTOMY: A PILOT STUDY ASSESSING FEASIBILITY AND UTILITY
Radical cystectomy (RC) is a complicated procedure associated with significant morbidity and lengthy recovery. Wearable fitness trackers (WFT) offer a novel means of objectively evaluating and quantifying patient behavioral patterns. We sought to determine capacity for use of these devices to measure patient sleep and activity levels in the perioperative setting.
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 199 (4) , e336
MP26-04 WEARABLE FITNESS TRACKERS FOR MEASUREMENT OF BEHAVIORAL PATTERNS AMONG PATIENTS UNDERGOING RADICAL CYSTECTOMY: A PILOT STUDY ASSESSING FEASIBILITY AND UTILITY
Radical cystectomy (RC) is a complicated procedure associated with significant morbidity and lengthy recovery. Wearable fitness trackers (WFT) offer a novel means of objectively evaluating and quantifying patient behavioral patterns. We sought to determine capacity for use of these devices to measure patient sleep and activity levels in the perioperative setting.